Studies on the inhibition of insulin action in vitro by beta adrenergic blocking agents.
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D002245:Carbon Dioxide / Q000378:metabolism; D004336:Drug Antagonism; D004983:Ethanolamines / Q000494:pharmacology; D005227:Fatty Acids / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology*; D008297:Male; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*
D004983:Ethanolamines; D005227:Fatty Acids; D007328:Insulin; D013565:Sympatholytics; D002245:Carbon Dioxide; D011433:Propranolol; D005947:Glucose; D007545:Isoproterenol